Treatment for systemic lupus erythematosus
US5679651A · kind A · utility
2Cited by
0References
9Claims
0Family size
Inventor
Key dates
| Filing date | Jun 5, 1995 |
| Grant date | Oct 21, 1997 |
| Priority date | — |
| Expiry date | Jun 5, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/70
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Cytarabine (ara-C) is effective in the treatment of systemic lupus erythematosus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.